Remove 2002 Remove Drug Pricing Remove Hospitals
article thumbnail

Panel urges FDA to remove warnings on hormonal menopause therapy

BioPharma Dive

The study was stopped early in 2002 after researchers observed an increased risk of breast cancer and heart disease. During the meeting, Rachel Rubin, an assistant clinical professor in urology at Georgetown University Hospital and an adviser to Let’s Talk Menopause, urged the FDA to remove the box label. TechTarget, Inc.s

article thumbnail

Three strategies for managing loss of exclusivity successfully

pharmaphorum

Drug prices to plummet in wave of expiring patents”. Price decay after loss of brand exclusivity”. These are just three headlines that come up when you Google “drug patent expiry”. 6 The stakes were extremely high, with annual costs of insulin reaching $736 per patient in 2013, up threefold since 2002.